Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharmova rises after unit gets US FDA approval

** Shares of Jubilant Pharmova  JUBA.NS  up as much as 6.5%
to 438.90 rupees
    ** The pharma co said its unit Jubilant Draximage got U.S.
FDA approval for its abbreviated new drug application for
preparation kit of a drug used for treating breast and skin
cancer
    ** Over 673,000 shares change hands, 1.7x the 30-day moving
average
    ** Including session's move, stock up ~15% YTD
    

 (Reporting by Kashish Tandon in Bengaluru)
 ((kashish.tandon@thomsonreuters.com))

Recent news on Jubilant Pharmova

See all news